Product image of Ecugra (Ticagrelor) supplied by GNH India

Ecugra

Active Ingredient:
Ticagrelor
Origin:
EU

Ecugra (Ticagrelor)

Ecugra is a medication containing Ticagrelor, used to prevent blood clots in certain heart conditions. This oral medication is designed for cardiovascular health support.

Manufacturer / TM Owner

Bausch Health Ireland Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Ecugra, containing the active ingredient Ticagrelor, is primarily used to reduce the risk of blood clots in patients with acute coronary syndrome or those who have undergone certain heart procedures. It works by inhibiting platelet aggregation, which is crucial for maintaining blood flow and preventing cardiovascular events. People often ask, 'What is Ecugra used for?' and the answer lies in its role in managing conditions related to heart health and preventing clot formation.

Side Effects

  • Common effects of Ecugra may include bleeding or bruising more easily than usual. Some users might experience shortness of breath, dizziness, or nausea. These effects vary among individuals and are not exhaustive. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

  • Ecugra should be handled with care, especially by individuals with a history of bleeding disorders or those taking other blood-thinning medications. It is important to follow the guidance of a healthcare professional regarding its use. Store in a cool, dry place away from direct sunlight.

Avoid Interactions

  • Ecugra may interact with other medications, particularly those that affect blood clotting or are metabolized by the liver. Common interactants include NSAIDs, anticoagulants, and certain antifungal or antiviral drugs. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Ecugra is used to prevent blood clots in patients with acute coronary syndrome or those who have undergone certain heart procedures.

Ecugra should be stored in a cool, dry place away from direct sunlight.

Common effects may include bleeding or bruising more easily, shortness of breath, dizziness, or nausea.

Ecugra may interact with other medications, so it is important to consult a healthcare provider before combining it with other drugs.

Individuals with a history of bleeding disorders or those taking other blood-thinning medications should exercise caution with Ecugra.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ticagrelor

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT